PMID- 3437496 OWN - NLM STAT- MEDLINE DCOM- 19880404 LR - 20190919 IS - 0140-7783 (Print) IS - 0140-7783 (Linking) VI - 10 IP - 4 DP - 1987 Dec TI - The effect of age and diet on sulfadiazine/trimethoprim disposition following oral and subcutaneous administration to calves. PG - 331-45 AB - Thirty milligrams per kilogram of sulfadiazine/trimethoprim (SDZ/TMP, Tribrissen) was given orally and subcutaneously (s.c.) to two groups of male, Holstein calves. One group was fed milk-replacer throughout the 13-week period of the study while the second group was weaned onto a chopped grain-fiber mixture when 5 weeks old. Serum and urine were assayed for concentrations of unchanged drug. Trimethoprim bioavailability, following oral administration at 1, 6 and 12 weeks of age, is higher in milk-fed calves (non-ruminants) than in grain-fiber-fed calves (ruminants); bioavailability decreases with increasing age in both groups of calves. Serum concentrations above 0.1 micrograms/ml (the level of sensitivity of the assay) could not be obtained in ruminating calves. The rate of SDZ absorption following oral administration, as determined by the Wagner-Nelson method, was very slow in all the calves in this study with average half-life values ranging from 8.2-12.67 h; absorption was slightly faster in ruminating calves. Absorption of SDZ is rate-limiting and determines the biological half-life of the drug; SDZ serum concentrations above 2 micrograms/ml were maintained in all calves for at least 24 h. Following s.c. administration of Tribrissen to 7-and 13-week-old calves, urinary excretion patterns indicated that TMP was slowly released from the injection site; serum concentrations were below 0.1 micrograms/ml. In contrast, absorption of SDZ was very rapid; values for tmax were 1.5-1.8 h. The pharmacokinetic parameters for SDZ were calculated according to a one-compartment open model; neither diet nor age had a significant effect on SDZ disposition following s.c. injection. Subcutaneous administration of 30 mg/kg Tribrissen, b.i.d., may be the best therapeutic regimen; even though measureable concentrations of TMP cannot be achieved in the serum following a single s.c. dose, TMP concentrations should accumulate and, because of its sustained release, provide almost continual potentiation of SDZ. FAU - Shoaf, S E AU - Shoaf SE AD - Department of Pharmacology, New York State College of Veterinary Medicine, Cornell University, Ithaca 14853. FAU - Schwark, W S AU - Schwark WS FAU - Guard, C L AU - Guard CL LA - eng PT - Journal Article PT - Research Support, U.S. Gov't, Non-P.H.S. PL - England TA - J Vet Pharmacol Ther JT - Journal of veterinary pharmacology and therapeutics JID - 7910920 RN - 0 (Drug Combinations) RN - 0N7609K889 (Sulfadiazine) RN - 39474-58-3 (sulfadiazine, trimethoprim drug combination) RN - AN164J8Y0X (Trimethoprim) SB - IM MH - Absorption MH - Administration, Oral MH - Age Factors MH - Animals MH - Biological Availability MH - Cattle/*metabolism MH - Diet MH - Drug Combinations/administration & dosage/metabolism MH - Drug Synergism MH - Half-Life MH - Injections, Subcutaneous/veterinary MH - Male MH - Sulfadiazine/administration & dosage/*metabolism/*pharmacokinetics MH - Trimethoprim/administration & dosage/*metabolism/*pharmacokinetics EDAT- 1987/12/01 00:00 MHDA- 1987/12/01 00:01 CRDT- 1987/12/01 00:00 PHST- 1987/12/01 00:00 [pubmed] PHST- 1987/12/01 00:01 [medline] PHST- 1987/12/01 00:00 [entrez] AID - 10.1111/j.1365-2885.1987.tb00110.x [doi] PST - ppublish SO - J Vet Pharmacol Ther. 1987 Dec;10(4):331-45. doi: 10.1111/j.1365-2885.1987.tb00110.x.